Pfizer, one of the front-runners in the quest for a COVID-19 vaccine, said its candidate vaccine looks safe, and the company expects to have data next month on how well it protects people against ...

A combination Covid-flu vaccination developed by Pfizer Inc. and BioNTech SE missed on one of its goals in a final-stage trial, a setback for the companies as they search for lucrative new uses of ...

In November 2020, Pfizer released a statement sharing the results of its COVID-19 vaccine trials, stating that its vaccine was "95% effective against COVID-19 beginning 28 days after the first dose." ...

In June, Pfizer, along with its German partner BioNTech, asked the FDA to approve a new version of its Covid-19 vaccine booster designed to protect against XBB.1.5, a coronavirus subvariant that ...

Pfizer plans to sell the Covid vaccine it developed with BioNTech at $110 to $130 per dose for teens and adults once the U.S. government stops paying for them, the drugmaker said Friday.

A senior Pfizer executive has admitted that the drug company did not know whether its Covid vaccine prevented transmission of the virus when it began rolling out the shots globally.

Pfizer and BioNTech will request authorization from the US Food and Drug Administration this week for their three-dose COVID-19 vaccine for children ages 6 months to under 5 years, the companies ...

As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.

Pfizer is also running a study to see if the pills help people who’ve only been exposed to covid-19, as a sort of prophylactic treatment. “It’s a tight window: two days to get tested and ...

The Food and Drug Administration authorized Pfizer’s Paxlovid for mild to moderate Covid in people as young as 12 who have underlying conditions that raise the risk of hospitalization and death ...

The FDA has authorized the first oral antiviral to treat COVID-19. Pfizer's Paxlovid shows promise for reducing both hospitalization and death.

Pfizer's Covid-19 antiviral pills being manufactured in a laboratory in Freiburg, Germany. The Paxlovid pill has been shown to cut hospitalization or death by nearly 90 percent among newly ...